What’s Gilead’s Deal? Cash Burns Hole in Investors’ Pockets
This article is for subscribers only.
In the drug industry’s biggest-ever period for deals, one wildly successful company with a multibillion-dollar war chest has been oddly silent.
So what’s Gilead Sciences Inc. waiting for?